NCT02584842View on ClinicalTrials.gov

Rivaroxaban in Endovenous Laser Ablation With and Without Miniphlebectomy

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Varicose VeinsVenous ThrombosisThromboembolismBleeding
Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT02584842 - Rivaroxaban in Endovenous Laser Ablation With and Without Miniphlebectomy | Biotech Hunter | Biotech Hunter